Patent · US Expired

Process for the manufacture of form 1 ranitidine hydrochloride

US5621120A · kind A · utility

1Cited by
3References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 1994
Grant dateApr 15, 1997
Priority date
Expiry dateJun 24, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/52
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the manufacture of Form 1 ranitidine hydrochloride (N-[2-[[[5-(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl-N'-methyl-2- nitro-1,1-ethenediamine) hydrochloride, is described. A process to convert ranitidine hydrochloride Form 2 to Form 1 is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.